Critical Analysis: Nyxoah (NASDAQ:NYXH) vs. Globus Medical (NYSE:GMED)

Nyxoah (NASDAQ:NYXH) and Globus Medical (NYSE:GMED) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation.

Volatility and Risk

Nyxoah has a beta of 1.43, suggesting that its share price is 43% more volatile than the S&P 500. Comparatively, Globus Medical has a beta of 1.15, suggesting that its share price is 15% more volatile than the S&P 500.

Insider & Institutional Ownership

95.2% of Globus Medical shares are held by institutional investors. 17.1% of Nyxoah shares are held by insiders. Comparatively, 18.5% of Globus Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Nyxoah and Globus Medical’s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nyxoah	$5.13 million	45.72	-$46.77 million	($1.64)	-5.73
Globus Medical	$1.57 billion	6.23	$122.87 million	$0.64	112.72

Globus Medical has higher revenue and earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Nyxoah and Globus Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nyxoah	0	1	5	0	2.83
Globus Medical	0	4	7	0	2.64

Nyxoah presently has a consensus price target of $17.80, suggesting a potential upside of 89.36%. Globus Medical has a consensus price target of $73.30, suggesting a potential upside of 1.61%. Given Nyxoah’s stronger consensus rating and higher possible upside, analysts plainly believe Nyxoah is more favorable than Globus Medical.

Profitability

This table compares Nyxoah and Globus Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nyxoah	-843.49%	-42.14%	-33.55%
Globus Medical	3.51%	8.82%	7.06%

Summary

Globus Medical beats Nyxoah on 10 of the 14 factors compared between the two stocks.

About Nyxoah

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

About Globus Medical

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.